Daniel Zlatin, Author at Waldenstrom's Macroglobulinemia Foundation of Canada

January 2020: CancerCare presents Coping with a Loved One’s WM

2021-01-18T17:06:00-05:00

The organization CancerCare put together a workshop entitled “For Caregivers: Coping with a Loved One's Waldenstrom’s Macroglobulinemia”. It brought together: Carolyn Messner (director of Education and Training at CancerCare), Carl Harrington (chairman of the IWMF), Dr. Jeffrey V. Matous (from the Colorado Blood Cancer Institute), and Georgie Cusack (Director of Education and Patient Safety, National Institutes of Health). You can listen to the workshop at the following link. For Caregivers: Coping with a Loved One's WM

January 2020: CancerCare presents Coping with a Loved One’s WM2021-01-18T17:06:00-05:00

March 2020: CancerCare presents “The Latest in the Treatment of WM”

2021-01-18T17:06:46-05:00

The organization CancerCare put together a workshop entitled "The Latest News in the Treatment of Waldenstrom’s Macroglobulinemia". It brought together: Carolyn Messner (director of Education and Training at CancerCare), Carl Harrington (chairman of the IWMF), Dr. Christian Buske (a noted WM researcher from Germany), and Dr. Steven Treon (from the Bing Center for WM at the Dana Farber Cancer Institute). You can listen to the workshop at the following link. Dr. Treon and Dr. Buske, "The Latest News in WM"

March 2020: CancerCare presents “The Latest in the Treatment of WM”2021-01-18T17:06:46-05:00

August 2020: Dr. Treon discusses “Next Gen BTK Inhibitors”

2021-01-18T17:12:17-05:00

The Toronto support group invited Dr. Treon to join them. He led them through a discussion of how the research on BTK inhibitors is progressing towards new drug offerings. View the recorded Zoom session at the link below. Dr. Treon presents Next Gen BTK Inhibitors

August 2020: Dr. Treon discusses “Next Gen BTK Inhibitors”2021-01-18T17:12:17-05:00

June 2020: Dr. Hunter presentation to the Halifax support group

2021-01-18T17:09:44-05:00

In mid-2020, Dr. Zachary Hunter spoke at an Atlantic Support Group Zoom Meeting. Click on the link below to view his presentation entitled “What is New in Waldenstrom’s Macroglobulinemia Research?”. His talk is followed by a question and answer session. Dr. Hunter's Presentation and Q&A

June 2020: Dr. Hunter presentation to the Halifax support group2021-01-18T17:09:44-05:00

May 2020: Dr. Castillo’s “Ask the Doctor” session

2021-01-18T17:08:42-05:00

Dr. Jorge Castillo participated in a Zoom meeting with the Philadelphia support group. They recorded the session and kindly shared it with all of us. The link and password for viewing are available at the IWMF page, below. Dr. Castillo "Ask the Doctor"

May 2020: Dr. Castillo’s “Ask the Doctor” session2021-01-18T17:08:42-05:00

Dec. 2020: IWMF Q&A on WM and COVID-19

2021-01-27T17:35:12-05:00

On Dec. 23, 2020, our sister organization the IWMF issued a list of Q&A on the subject of Covid-19. The bottom line is: "When asked whether WM patients should be vaccinated for COVID-19, every WM specialist contacted agreed that it would be prudent to do so but to consult with your cancer doctor first." IWMF COVID-19 NEWS BRIEF – DECEMBER 2020 The coronavirus (COVID-19) pandemic has affected the global community, with each country developing safety protocols of different types and durations. We know that the IWMF community has many questions about the vaccine, and we hope this news brief offers [...]

Dec. 2020: IWMF Q&A on WM and COVID-192021-01-27T17:35:12-05:00

April 2020: Ibrutinib and Covid-19

2021-01-18T17:07:58-05:00

As a follow up to the article that appeared in Forbes magazine, Blood, the world’s leading haematology magazine, has published an article by Dr. Steve Treon. In the article, Dr. Treon explains the logic and process of ibrutinib’s possible effect on COVID-19. We have provided a .pdf of the article here. Of extra interest to WMFC members is the reference to the transgenic mouse model which has been through two stages of research that the WMFC has funded and supported with Dr. Treon at the Dana Farber Cancer Institute over the last five or six years. .PDF of Dr. Treon's [...]

April 2020: Ibrutinib and Covid-192021-01-18T17:07:58-05:00

Dec. 2020: Dr. Castillo Discusses Covid-19 Vaccines

2021-01-27T17:34:01-05:00

On Dec. 2, 2020, the Support Group leaders from across the US and Canada got together over Zoom. There are three sections to the video. The most important is the following one, given the current Covid situation: From approximately the 22 minute mark to the 34 minute point, Dr. Castillo of the Dana-Farber Bing Center discusses the leading Covid-19 candidates, and his take on their safety and efficacy in WM patients. The other two sections of the video include: From approximately 36:50 to 42:00, there is a discussion of topics presented at the recent ASH 2020 conference (American Society of [...]

Dec. 2020: Dr. Castillo Discusses Covid-19 Vaccines2021-01-27T17:34:01-05:00

Sept. 2020: Update on Management of WM and Future Research Directions

2021-01-18T17:16:20-05:00

An article entitled "2020 Update on Management and Future Directions" was published in the journal "Clinical Lymphoma, Myeloma and Leukemia". You can see it here. 2020 Update on Management of WM

Sept. 2020: Update on Management of WM and Future Research Directions2021-01-18T17:16:20-05:00

October 2020: National Zoom Meeting with Dr. Treon

2021-01-27T17:32:54-05:00

In October, 2020, we had a national WMFC meeting (via Zoom, of course). Our guest was Dr. Steve Treon of DFCI. The topic of his presentation was "Genomic and Treatment Advances in WM". The recording of the meeting is available, below. Genomic and Treatment Advances in WM

October 2020: National Zoom Meeting with Dr. Treon2021-01-27T17:32:54-05:00

DRZ

About Daniel Zlatin